Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 416 | 3 | MITOCHONDRIA//ARGINASE//NADPH OXIDASE | 30587 |
| 1344 | 2 | ARGINASE//CYSTINURIA//UREA CYCLE | 8627 |
| 25926 | 1 | ARGININE DEIMINASE//ARGININE DEPRIVATION//ADI PEG20 | 289 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ARGININE DEIMINASE | authKW | 3722328 | 22% | 53% | 64 |
| 2 | ARGININE DEPRIVATION | authKW | 1766676 | 6% | 90% | 18 |
| 3 | ADI PEG20 | authKW | 872435 | 3% | 100% | 8 |
| 4 | ARGININOSUCCINATE SYNTHETASE | authKW | 804471 | 10% | 25% | 29 |
| 5 | RECOMBINANT HUMAN ARGINASE | authKW | 545272 | 2% | 100% | 5 |
| 6 | ARGININE STARVATION | authKW | 389477 | 2% | 71% | 5 |
| 7 | PHOENIX PHARMACOL INC | address | 327163 | 1% | 100% | 3 |
| 8 | RECOMBINANT ARGININE DEIMINASE | authKW | 327163 | 1% | 100% | 3 |
| 9 | ARGININE DEPLETION | authKW | 245371 | 1% | 75% | 3 |
| 10 | ARGININOSUCCINATE SYNTHETASE ASS | authKW | 245371 | 1% | 75% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 2078 | 44% | 0% | 128 |
| 2 | Cell Biology | 251 | 17% | 0% | 48 |
| 3 | Biotechnology & Applied Microbiology | 132 | 10% | 0% | 30 |
| 4 | Biochemistry & Molecular Biology | 107 | 20% | 0% | 57 |
| 5 | Hematology | 35 | 4% | 0% | 12 |
| 6 | Biochemical Research Methods | 33 | 4% | 0% | 13 |
| 7 | Medicine, Research & Experimental | 33 | 5% | 0% | 15 |
| 8 | Biophysics | 26 | 4% | 0% | 13 |
| 9 | Pharmacology & Pharmacy | 12 | 7% | 0% | 19 |
| 10 | Medical Laboratory Technology | 6 | 1% | 0% | 3 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHOENIX PHARMACOL INC | 327163 | 1% | 100% | 3 |
| 2 | SYLVERSTER COMPREHENS CANC | 218109 | 1% | 100% | 2 |
| 3 | ADV SCI TECHNOL COMMERICALIZAT | 109054 | 0% | 100% | 1 |
| 4 | BIOMEDES | 109054 | 0% | 100% | 1 |
| 5 | CANC DRUG RD | 109054 | 0% | 100% | 1 |
| 6 | CANCER PROTEOM GRP | 109054 | 0% | 100% | 1 |
| 7 | GENET ONCOL ONCOL TRANSLAZ | 109054 | 0% | 100% | 1 |
| 8 | GUT MICROBIOL IMMUNOL GRP CENT EXCELLENCE ADV S | 109054 | 0% | 100% | 1 |
| 9 | HISTOPATHOL ISH | 109054 | 0% | 100% | 1 |
| 10 | NEUROVASC COORDIANT | 109054 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CELL DEATH & DISEASE | 1470 | 2% | 0% | 6 |
| 2 | CANCER BIOCHEMISTRY BIOPHYSICS | 1185 | 1% | 1% | 2 |
| 3 | CANCER LETTERS | 867 | 3% | 0% | 10 |
| 4 | TRANSLATIONAL ONCOLOGY | 705 | 1% | 0% | 2 |
| 5 | INVESTIGATIONAL NEW DRUGS | 666 | 1% | 0% | 4 |
| 6 | JOURNAL OF BIOMEDICAL SCIENCE | 557 | 1% | 0% | 3 |
| 7 | JOURNAL OF HEMATOLOGY & ONCOLOGY | 539 | 1% | 0% | 2 |
| 8 | ONCOTARGET | 529 | 3% | 0% | 9 |
| 9 | INTERNATIONAL JOURNAL OF CANCER | 518 | 3% | 0% | 10 |
| 10 | BRITISH JOURNAL OF CANCER | 473 | 3% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |